/INBX

Inhibrx Biosciences Inc

INBX

$109.27USD↓-1.93%-2.15 today

MARKET CAP

1.6B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$109 – $115

52W RANGE

$26

$155

AI Summary

Stalk

StalkMedium

INBX displayed a Bearish Exhaustion candle at a key support area, signaling a potential bottoming bounce into the 50-day SMA and 200-day SMA zone. While medium-term bias remains bullish under the higher-highs higher-lows regime and exhaustion signal, price currently sits below the 9- and 20-period EMAs and requires a clearer acceptance of the support zone. Execution will be deferred until pullbacks into this structural support are reliably held.

↑FDA accepted ozekibart BLA for oncology; review set April 14, 2027.
↑$325 M debt facility (Oxford Finance) with $100 M funded in July for R&D.
↓Q2 2026 net loss $36.7 M ($2.34/share) underscores weak profitability.

Full analysis →

Buying

10

institutions

Selling

5

institutions

New Positions

5

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
PA Perceptive Advisors LLC Q2 2026	SELL	1.30 M	122.96 M	+-1.59 M	-36.6%	1.85%
VG Viking Global Investors LP Q2 2026	SELL	1.12 M	106.49 M	+-313.78 K	+10.2%	0.30%
BI Blackrock, Inc. Q2 2026	BUY	825.97 K	78.26 M	+27.07 K	+45.7%	0.00%
WP Woodline Partners LP Q2 2026	SELL	400.89 K	37.98 M	+-367.97 K	-26.5%	0.12%
MM Millennium Management LLC Q2 2026	SELL	147.20 K	13.95 M	+-180.66 K	-36.7%	0.01%
RT Renaissance Technologies LLC Q2 2026	BUY	62.20 K	5.89 M	+12.02 K	+74.7%	0.01%
VI Voloridge Investment Management, LLC Q2 2026	BUY	48.77 K	4.62 M	+35.26 K	+409.1%	0.02%
CA Citadel Advisors LLC Q2 2026	SELL	42.70 K	4.05 M	+-28.46 K	-15.4%	0.00%
HS Hussman Strategic Advisors, Inc. Q2 2026	BUYNEW	31.50 K	2.98 M	+31.50 K	+0.0%	0.69%
PA Point72 Asset Management, L.P. Q2 2026	BUYNEW	26.01 K	2.46 M	+26.01 K	+0.0%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	11.25 K	1.07 M	+2.87 K	+89.2%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUYNEW	7.65 K	724.74 K	+7.65 K	+0.0%	0.01%
JC Jpmorgan Chase & Co Q2 2026	BUY	5.26 K	502.33 K	+328.00	+70.1%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUYNEW	6.80 K	457.37 K	+6.80 K	+0.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	BUYNEW	4.73 K	447.98 K	+4.73 K	+0.0%	0.00%